Nancy J. Hutson, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 105,000 shares at $15.40 ($1.6M) on 2021-10-15, disclosed to the SEC on 2021-10-19.
Open-market sale of $1.6M BCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CLSD | BUY | 2023-10-04 | $9K | — | Filing → |
| BCRX | SELL | 2023-06-15 | $207K | — | Filing → |
| CLSD | BUY | 2022-11-21 | $40K | — | Filing → |